
|Articles|April 2, 2009
Supplements and Featured Publications
- Cost-Effectiveness and Outcome Optimization Strategies in the Treatment of Residual Cardiovascular R
- Volume 15
- Issue 3
Cost-Effectiveness and Outcome Optimization Strategies in the Treatment of Residual Cardiovascular Risk Beyond LDL Cholesterol in the Managed Care Setting
Advertisement
Articles in this issue
over 16 years ago
Introductionover 16 years ago
Participating Facultyover 16 years ago
The Impact of Residual CVD Risk in the Managed Care SettingNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Most Favored Nation Drug Pricing Moves Forward, but Experts Warn Details Are Still Missing
2
Explore the Clinical Data for JOURNAVX® (suzetrigine)
3
FDA Approves Lumateperone as Add-On Therapy for Major Depressive Disorder
4
Oncology Landscape Continues to Evolve With Expanded Indications, First-in-Class Therapies
5















































